http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-45282-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1cd6051bf69f25a0652ded4e4edac31 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 1977-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-45282-L |
| titleOfInvention | Pharmaceutical tablet formulation |
| abstract | There is described a pharmaceutical tablet formulation comprising an anti-allergic drug having sodium cromoglycate like activity, as active ingredient, in combination with a lubricant and a diluent (and preferably also a flow aid and a binder) the low aid, binder, lubricant and diluent containing no material capable of causing an adverse reaction in an allergic patient. Unit dosage forms of 6,7,8,9-tetrahydro-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-carboxylic acid and 6,7,8,9-tetrahydro-S-hydroxy-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-ccarboxylic acid are also described. The formulations and unit dosage forms are indicated for use in the treatment of allergies.n[CA1105835A] |
| priorityDate | 1976-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2882 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504916 |
Total number of triples: 16.